JANライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:42):

Stats
本日の出来高	168 418
平均出来高	323 404
時価総額	40.83M
EPS	$0 ( 2024-04-02 )
次の収益日	( $0 ) 2024-05-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.110
ATR14	$0.0580 (1.22%)

Insider Trading

Date	Person	Action	Amount	type
2023-01-05	Isaac Antonios	Buy	125 787	Common Stock
2023-01-05	Johnson Virland A	Buy	78 617	Common Stock
2021-05-24	Johnson Virland A	Sell	32 933	Common Shares
2020-11-03	Johnson Virland A	Sell	1 469	Common Stock
2021-02-05	Johnson Virland A	Sell	4 112	Common Stock

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 390 604 \| Sell: 701 030

ボリューム相関

長: -0.07 (neutral)

短: 0.86 (strong)

Signal:(28.643) Same movement expected

Janone Inc 相関

10 最も正の相関
SMMF	0.943
SHBI	0.939
FRBA	0.937
ORRF	0.936
MPB	0.933
SMBC	0.932
AMAL	0.93
PPBI	0.925
SPFI	0.925
CZNC	0.922

10 最も負の相関
TZPSU	-0.898
EBACU	-0.897
ECHO	-0.896
WMPN	-0.887
TCMD	-0.884
ARDX	-0.883
PFMT	-0.883
EXAS	-0.882
FWONK	-0.882
TZPS	-0.882

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Janone Inc 相関 - 通貨/商品

-0.04
( neutral )

-0.16
( neutral )

0.00
( neutral )

-0.35
( neutral )

-0.64
( weak negative )

-0.07
( neutral )

Janone Inc 財務諸表

Annual	2023
収益:	$0
総利益:	$-1.50M (0.00 %)
EPS:	$-5.01

FY	2023
収益:	$0
総利益:	$-1.50M (0.00 %)
EPS:	$-5.01

FY	2022
収益:	$39.61M
総利益:	$7.62M (19.23 %)
EPS:	$1.140

FY	2021
収益:	$40.02M
総利益:	$8.87M (22.16 %)
EPS:	$-6.35

Financial Reports:

No articles found.

Janone Inc

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.